MMedication Read More Trump, RFK Jr. and Texas lawsuits slam KenvueNovember 3, 2025 Kenvue, the company that makes Tylenol, is fighting on both the political and scientific fronts. The latest blow…
BBusiness Read More Kimberly-Clark to buy Kenvue in $48.7 billion dealNovember 3, 2025 Huggies, manufactured by Kimberly-Clark and Band-Aid, manufactured by Kenvue. Getty Images Kimberly-Clark announced Monday it’s struck an agreement…
HHealth care Read More 3 Healthcare Stocks to Buy Hand Over Fist in OctoberOctober 27, 2025 Intuitive Surgical just put up a strong quarter, reminding Wall Street that it is a growth stock. Merck…
HHealth care Read More 3 Healthcare Stocks Paying the Highest Dividends of 2025October 27, 2025 Kenvue was spun off from Johnson & Johnson in mid-2023, and its life is starting out a little…
HHealth care Read More J&J lays out plan to splinter orthopedics business into separate companyOctober 19, 2025 Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.…
BBusiness Read More Wall Street wavers as trade tensions flare again with ChinaOctober 14, 2025 NEW YORK (AP) — Stocks wavered on Wall Street Tuesday as trade tensions escalate again with China. The…
HHealth care Read More J&J lays out plan to splinter orthopedics business into separate companyOctober 14, 2025 Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.…
HHealth care Read More J&J in talks to acquire Protagonist TherapeuticsOctober 13, 2025 Johnson & Johnson (J&J) is in discussions to purchase Protagonist Therapeutics, a move that would enhance their current…
MMarkets Read More Big Bank Earnings, Fed Speakers, Shutdown Data DelaysOctober 12, 2025 Kena Betancur / VIEWpress / Getty Images JPMorgan is set to kick off a string of earnings report…
MMarkets Read More Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034October 6, 2025 DelveInsight Business Research LLP The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional symptom-focused strategies toward…
UUnited States Read More Trump pharmaceutical tariff threat lessens after Pfizer dealOctober 1, 2025 U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with…
AArtificial intelligence Read More Why the crazy spending of this AI boom isn’t like the dot-com bubbleSeptember 28, 2025 If I hear one more hedge fund oligarch on television tell me that the data center buildout/artificial intelligence…